# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-25-004996
Filing Date
2025-04-18
Accepted
2025-04-18 09:30:19
Documents
19
Period of Report
2025-06-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | xlo-20250610xpre14a.htm iXBRL | PRE 14A | 840082
2 | GRAPHIC | xlo-20250610xpre14a_a003.jpg | GRAPHIC | 9237
3 | GRAPHIC | xlo-20250610xpre14a_a004.jpg | GRAPHIC | 1490
4 | GRAPHIC | xlo-20250610xpre14a_bg001.jpg | GRAPHIC | 123093
5 | GRAPHIC | xlo-20250610xpre14a_bg002.jpg | GRAPHIC | 93788
| Complete submission text file | 0001558370-25-004996.txt |  | 1778119

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | xlo-20250610.xsd | EX-101.SCH | 3661
7 | EX-101.LAB | xlo-20250610_lab.xml | EX-101.LAB | 3685
8 | EX-101.PRE | xlo-20250610_pre.xml | EX-101.PRE | 3518
21 | EXTRACTED XBRL INSTANCE DOCUMENT | xlo-20250610xpre14a_htm.xml | XML | 48525

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40925 | Film No.: 25849321
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)